MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS
|
Back to Search Results |
|
Model Number 37603 |
Device Problems
Failure to Deliver Energy (1211); Unintended Collision (1429); Energy Output Problem (1431); Inappropriate/Inadequate Shock/Stimulation (1574); Low impedance (2285); Battery Problem (2885)
|
Patient Problems
Discomfort (2330); Shaking/Tremors (2515); Electric Shock (2554); Cramp(s) /Muscle Spasm(s) (4521)
|
Event Date 11/23/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from the manufacturer¿s representative (rep) who reported on november 23rd the patient woke up with a return of symptoms; tremors.The consumer tried to make changes/adjustments and got shocked (didn¿t know what they were doing when the shock occurred).On july 13th adjustments were made as such: group a: 2.5 (3.0v upper range) c+1-, 180hz, 60us group b: 2.35v, c+0, 180hz, 60us group c: 3.5 (4.0 upper range) 0+1-, 180hz, 60us.Currently the implant was interrogated which showed the elective replacement indicator (eri) but stimulation was on group c at 3.5 v.The rep then adjusted to group b (1.85v) but the consumer had issues with their hand cramping and discomfort with stimulation.The consumer was adjusted to group a with the same issue in the hand with the amplitude set to 2.05v.It was recommended to read the device with the tablet as soon as possible.
|
|
Event Description
|
Additional information was received from the consumer reporting that the patient is getting electrical sensation in their neck down arm and in general, all over upper extremities on both sides along with return of tremor.The ins is at eri at 2.38v.Impedances were checked and all monopolar pairs were green in the range of 527-806 ohms.The bipolars ranged from 744-938 ohm except for 0-1 pair that showed red with "low".The patient uses group c at 3.5v which is programmed in bipolar on 0-1 and also has group a with c-1 and group b with c-0.The rep ran impedances at 1.5v and received the same results as before when they were ran at 0.7v.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the manufacturer representative (rep) reporting the patient suffered from a fall around or on thanksgiving day 2021.It¿s believed this is the root cause of the electrical sensation and impedance issues.The rep met with the healthcare provider (hcp) and patient on (b)(6) 2021 and was able to assess the patient's system.It was discovered that contact 01 were damaged, unusable and not providing therapy.They programmed around the issue and used contact 2.The patient is receiving therapy and happy with the results.He is currently scheduled to have his battery replaced on (b)(6) 2022.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from the manufacturer¿s representative (rep) reported the fall was not related to the dbs device or therapy.
|
|
Search Alerts/Recalls
|
|
|